UK markets closed

Novozymes A/S (NVZMY)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
63.07+0.71 (+1.14%)
As of 11:22AM EDT. Market open.
Show:
Annual

Income statement

Currency in DKK. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
17,899,000
17,899,000
17,553,000
14,951,000
14,012,000
Cost of revenue
8,177,000
8,177,000
7,976,000
6,328,000
6,159,000
Gross profit
9,722,000
9,722,000
9,577,000
8,623,000
7,853,000
Operating expenses
Research development
2,017,000
2,017,000
2,001,000
2,009,000
1,937,000
Selling general and administrative
3,324,000
3,324,000
3,223,000
2,795,000
2,320,000
Total operating expenses
5,258,000
5,258,000
5,149,000
4,738,000
4,243,000
Operating income or loss
4,464,000
4,464,000
4,428,000
3,885,000
3,610,000
Interest expense
173,000
173,000
102,000
102,000
63,000
Income before tax
3,909,000
3,909,000
4,556,000
3,924,000
3,521,000
Income tax expense
870,000
870,000
870,000
779,000
695,000
Income from continuing operations
3,039,000
3,039,000
3,686,000
3,145,000
2,826,000
Net income
3,024,000
3,024,000
3,676,000
3,146,000
2,825,000
Net income available to common shareholders
3,024,000
3,024,000
3,676,000
3,146,000
2,825,000
Basic EPS
11.60
10.92
13.29
11.32
10.07
Diluted EPS
11.55
10.88
13.19
11.23
10.02
Basic average shares
276,869
277,035
276,644
277,919
280,428
Diluted average shares
277,759
277,875
278,734
280,228
282,023